-
公开(公告)号:AU724447B2
公开(公告)日:2000-09-21
申请号:AU6889296
申请日:1996-09-04
Applicant: FUSO PHARMACEUTICAL IND
Inventor: NAKAZAWA TERUKI , ARAKI HIROMASA , KISHI YUICHIRO , SHINODA SANJI , YAMADA MORIYUKI , OHASHI KAZUTOMO
IPC: A01K67/02 , A01K67/027 , C12N5/02 , C12N5/073
Abstract: The present invention aims to provide a medium composition for in vitro fertilization, in particular, a composition usable in the culture of ova or early embryos which are fertilized eggs, the preparation or culture of sperm, and the pre-treatment of ova or sperm. The composition comprises, as its essential components, L-phenylalanine, L-tryptophan, L-lysine, L-threonine, L-valine, L-methionine, L-isoleucine, L-leucine, L-proline, glycine, L-alanine, L-tyrosine, L-histidine, L-arginine, L-taurine, L-aspartic acid, L-serine, L-asparagine, L-glutamic acid, L-glutamine and L-cystine, provided that at least a part of the L-cystine may be replaced by L-cysteine.
-
公开(公告)号:PT1283214E
公开(公告)日:2007-03-30
申请号:PT01922014
申请日:2001-04-23
Applicant: FUSO PHARMACEUTICAL IND
Inventor: WAKAMIYA NOBUTAKA , KESHI HIROYUKI , OHTANI KATSUKI , SAKAMOTO TAKASHI , KISHI YUICHIRO
-
公开(公告)号:PT872180E
公开(公告)日:2003-09-30
申请号:PT96929521
申请日:1996-09-04
Applicant: FUSO PHARMACEUTICAL IND
Inventor: NAKAZAWA TERUKI , ARAKI HIROMASA , KISHI YUICHIRO , SHINODA SANJI , YAMADA MORIYUKI , OHASHI KAZUTOMO
IPC: A01K67/02 , A01K67/027 , C12N5/02 , C12N5/073 , C12N5/00
Abstract: The present invention aims to provide a medium composition for in vitro fertilization, in particular, a composition usable in the culture of ova or early embryos which are fertilized eggs, the preparation or culture of sperm, and the pre-treatment of ova or sperm. The composition comprises, as its essential components, L-phenylalanine, L-tryptophan, L-lysine, L-threonine, L-valine, L-methionine, L-isoleucine, L-leucine, L-proline, glycine, L-alanine, L-tyrosine, L-histidine, L-arginine, L-taurine, L-aspartic acid, L-serine, L-asparagine, L-glutamic acid, L-glutamine and L-cystine, provided that at least a part of the L-cystine may be replaced by L-cysteine.
-
公开(公告)号:DE69628039D1
公开(公告)日:2003-06-12
申请号:DE69628039
申请日:1996-09-04
Applicant: FUSO PHARMACEUTICAL IND
Inventor: NAKAZAWA TERUKI , ARAKI HIROMASA , KISHI YUICHIRO , SHINODA SANJI , YAMADA MORIYUKI , OHASHI KAZUTOMO
IPC: A01K67/02 , A01K67/027 , C12N5/02 , C12N5/073 , C12N5/00
Abstract: The present invention aims to provide a medium composition for in vitro fertilization, in particular, a composition usable in the culture of ova or early embryos which are fertilized eggs, the preparation or culture of sperm, and the pre-treatment of ova or sperm. The composition comprises, as its essential components, L-phenylalanine, L-tryptophan, L-lysine, L-threonine, L-valine, L-methionine, L-isoleucine, L-leucine, L-proline, glycine, L-alanine, L-tyrosine, L-histidine, L-arginine, L-taurine, L-aspartic acid, L-serine, L-asparagine, L-glutamic acid, L-glutamine and L-cystine, provided that at least a part of the L-cystine may be replaced by L-cysteine.
-
公开(公告)号:AU4884001A
公开(公告)日:2001-11-07
申请号:AU4884001
申请日:2001-04-23
Applicant: FUSO PHARMACEUTICAL IND
Inventor: WAKAMIYA NOBUTAKA , KESHI HIROYUKI , OHTANI KATSUKI , SAKAMOTO TAKASHI , KISHI YUICHIRO
IPC: C07K14/47 , C07K14/785 , C12N15/12 , A01K67/027 , C07K16/18 , C12P21/02 , G01N33/53
-
公开(公告)号:AU674694B2
公开(公告)日:1997-01-09
申请号:AU4761093
申请日:1993-08-10
Applicant: FUSO PHARMACEUTICAL IND
Inventor: MATSUHISA AKIO , SHIBA KIYOTAKA , MIKAWA YOSHIKAZU , KISHI YUICHIRO
IPC: C12Q1/68 , C12Q1/6813 , C12Q1/6816 , G01N27/447 , G01N33/50 , G01N33/58 , C12Q1/28 , C12Q1/42
Abstract: A method of detecting a nucleic acid which comprises bringing a solid carrier suspected to carry or contain a nucleic acid into contact with a polyamine containing, bound thereto, a label capable of generating a detectable signal or a precursor thereof to thereby form a complex between a nucleic acid, if any, and the polyamine, removing the polyamine which has not formed any complex before or after the conversion of the precursor, if used, into the label, and detecting the label.
-
公开(公告)号:CA2231148C
公开(公告)日:2007-12-04
申请号:CA2231148
申请日:1996-09-04
Applicant: FUSO PHARMACEUTICAL IND
Inventor: KISHI YUICHIRO , NAKAZAWA TERUKI , SHINODA SANJI , ARAKI HIROMASA , OHASHI KAZUTOMO , YAMADA MORIYUKI
IPC: A01K67/02 , A01K67/027 , C12N5/02 , C12N5/073
Abstract: The present invention aims to provide a medium composition for in vitro fertilization, in particular, a composition suitable for use in the culture of ova or early embryos which are fertilized eggs, the preparation or culture of sperm, and the pre-treatment of ova or sperm. The composition comprises, as its essential components, L-phenylalanine, L-tryptophan, L-lysine, L-threonine, L-valine, L-methionine, L-isoleucine, L-leucine, L-proline, glycine, L-alanine, L-tyrosine, L-histidine, L-arginine, L-taurine, L-aspartic acid, L-serine, L-asparagine, L-glutamic acid, L-glutamine and L-cystine, provided that at least a part of the L-cystine may be replaced by L-cysteine.
-
公开(公告)号:DK1283214T3
公开(公告)日:2007-06-11
申请号:DK01922014
申请日:2001-04-23
Applicant: FUSO PHARMACEUTICAL IND
Inventor: WAKAMIYA NOBUTAKA , KESHI HIROYUKI , OHTANI KATSUKI , SAKAMOTO TAKASHI , KISHI YUICHIRO
IPC: C07K14/47 , A01K67/027 , C07K14/785 , C07K16/18 , C12N15/12 , C12P21/02 , G01N33/53
-
公开(公告)号:DE60126602D1
公开(公告)日:2007-03-29
申请号:DE60126602
申请日:2001-04-23
Applicant: FUSO PHARMACEUTICAL IND
Inventor: WAKAMIYA NOBUTAKA , KESHI HIROYUKI , OHTANI KATSUKI , SAKAMOTO TAKASHI , KISHI YUICHIRO
IPC: C07K14/47 , A01K67/027 , C07K14/785 , C07K16/18 , C12N15/12 , C12P21/02 , G01N33/53
-
公开(公告)号:ES2198498T3
公开(公告)日:2004-02-01
申请号:ES96929521
申请日:1996-09-04
Applicant: FUSO PHARMACEUTICAL IND
Inventor: NAKAZAWA TERUKI , ARAKI HIROMASA , KISHI YUICHIRO , SHINODA SANJI , YAMADA MORIYUKI , OHASHI KAZUTOMO
IPC: A01K67/02 , A01K67/027 , C12N5/02 , C12N5/073 , C12N5/00
Abstract: The present invention aims to provide a medium composition for in vitro fertilization, in particular, a composition usable in the culture of ova or early embryos which are fertilized eggs, the preparation or culture of sperm, and the pre-treatment of ova or sperm. The composition comprises, as its essential components, L-phenylalanine, L-tryptophan, L-lysine, L-threonine, L-valine, L-methionine, L-isoleucine, L-leucine, L-proline, glycine, L-alanine, L-tyrosine, L-histidine, L-arginine, L-taurine, L-aspartic acid, L-serine, L-asparagine, L-glutamic acid, L-glutamine and L-cystine, provided that at least a part of the L-cystine may be replaced by L-cysteine.
-
-
-
-
-
-
-
-
-